Endosense
Who owns Endosense?
Endosense is a Belgian MedTech company, now owned by St. Jude Medical, which acquired it in 2013 from Ysios Capital Partners, Andera Partners and Gimv.
Hand-verified · updated 2026-09-30
Open JSON · CC-BYKey facts
- ·Fully exited in 2013 to St. Jude Medical.
- ·Average hold across 2 realized cycles: 4 years.
Ownership history
3 ownership periods · co-invest detected
Ysios Capital Partners sold Endosense to St. Jude Medical in 2013 after 4 years.
Andera Partners sold Endosense to St. Jude Medical in 2013 after 4 years.
Gimv sold Endosense to St. Jude Medical in 2013.
More from BioDiscovery 3
Other portfolio companies in the same fund.
More PE-backed in MedTech
Comparable medtech deals from other GPs.
Questions
Who owns Endosense?
Endosense is now owned by St. Jude Medical, which acquired it in 2013 from Ysios Capital Partners, Andera Partners and Gimv.
When did St. Jude Medical acquire Endosense?
St. Jude Medical acquired Endosense in 2013, buying from Ysios Capital Partners, Andera Partners and Gimv.
Who did Endosense sell to?
Ysios Capital Partners, Andera Partners and Gimv sold Endosense to St. Jude Medical in 2013 (Trade Sale).
Who has owned Endosense over time?
Endosense has been through 3 private-equity ownership periods: Ysios Capital Partners · via Ysios BioFund I · 2009–2013 · sold to St. Jude Medical · (Trade Sale); Andera Partners · via BioDiscovery 3 · 2009–2013 · sold to St. Jude Medical · (Trade Sale); Gimv · sold to St. Jude Medical · (Trade Sale).